Medicine Flashcards
Chest Pain - ix
bedside: ECG, CBG
blood: FBC, U&Es, Trops, lipids
imaging: CXR, Echocardiogram, CTA, CTPA
Chest Pain - differentials
Cardiac- ACS, stable angina, cardiac tamponade
Resp- pleural effusion, pneumonia, PE, pulmonary oedema
MSK- costochondritis, muscle strain [e.g. after coughing]
Psych- anxiety
GI- GORD, gastritis
Palpitations - ix
bedside: ECG
bloods: FBC, U&Es, Trops, lipid
imaging: ?
Palpitations - differential diagnosis
AF, cardiomyopathy, MI, HF, valvular disease, anaemia
other causes: alcohol, caffeine, medication s/e, ectopic beats, hormone changes [pregnancy or menopause], anxiety/stress, thyroid problems [hyperthyroidism], intense exercise, recreational drug use, smoking
Limb pain [and swelling] - ix
bed: examination [peripheral vascular exam], CBG
blood: FBC, U&Es, D-dimer
imaging: CXR, CTPA, X-ray of limb/joint in pain
special: Wells’ score
Limb pain [and swelling] - differential diagnosis
DVT/PE; fracture; arthritis; diabetic neuropathy
Syncope/presyncope - ix
bed: ECG, CBG, BP
blood: FBC, U&Es, CBG, CRP
imaging: Echocardiogram, X-ray[?], CT [?]
Syncope/presyncope - differential diagnosis
reflex syncope [vasovagal], orthostatic hypotension, arrhythmias, structural cardiopulmonary disease, seizures, intoxication, metabolic disturbances
Arrhythmias - definition
abnormal heart rhythms
result from interruption to normal electrical signals that co-ordinate contraction of the heart muscle
Arrhythmias - types
bradycardia
sinus tachycardia
atrial fibrillation and flutter
supraventricular tachycardia
ventricular tachycardia [shockable cardiac arrest rhythm]
ventricular fibrillation [shockable cardiac arrest rhythm]
pulseless electrical activity [non-shockable cardia arrest rhythm]
asystole [non-shockable cardia arrest rhythm]
Bradyarrhythmia’s - defintion
slow heart rhythms <60bpm
sinus brady, sinoatrial node disease, 1 HB, 2
HB [Mobitz T1 and T2], complete heart block, asystole
Supraventricular tachycardias - defintion
fast rhythms characterised by narrow QRS complexes, arrhythmogenic focus is supraventricular [atrial]
>100bpm
sinus tachy, atrial tachy, atrial flutter, atrial fibrillation
Atrial Flutter - electrical activity
Typically electric signal passes from atria, stimulating contraction, then disappears through the AVN and into ventricles. In Atrial Flutter, there is a re-entrant rhythm in either atrium. Electrical signal re-circulates in a self-perpetuating loop due to extra electrical pathway in the atria. Goes round and round the atrium without interruption. Typically atrial rate is 300bpm
Signal doesn’t enter the ventricles on every lap due to long refractory period of the AVN. Often results in two atrial contractions for every single ventricular contraction [2:1]
Atrial Flutter - ECG characteristics
Sawtooth appearance on ECG, repeated P waves occurring at around 300/min with narrow complex tachycardia
Atrial Flutter - causes
Structural heart disease, pulmonary disease, toxins [alcohol, caffeine]
Atrial Flutter - ix
ECG will reveal sawtooth appearance, diagnosing AFlutter
If unclear then can give AV nodal blocking manoeuvres to reveal repeated P waves
Atrial Flutter - mx
cardioversion is the best treatment - direct current cardioversion using a synchronised shock with rapidly and safely restore sinus rhythm
anticoagulation is recommended before cardioversion
Class Ia [flecainide], Ic [propafenone] or III [amiodarone] drugs may be used
Atrial Fibrillation - electrical activity
Disorganised random electrical activity in the atria, only intermittently conducted by AVN causing the irregularly irregular ventricular beat
Atrial Fibrillation - ECG characteristics
absent P waves and irregular baseline with a variable [irregularly irregular] ventricular response rate
range from 90-170bpm but can be faster/slower
Atrial Fibrillation - causes
Ischaemic heart disease, valvular heart disease, hypertension, pulmonary disease, sepsis/infection, thyrotoxicosis, alcohol excess
SMITH mnemonic:
Sepsis
Mitral valve pathology
Ischaemic heart disease
Thyrotoxicosis
Hypertension
can be paroxysmal [transient], persistent [lasts longer than a week], or permanent
Atrial Fibrillation - s/s
Often asymptomatic, but may be diagnosed after a stroke
May also present with palpitations, sob, dizziness or syncope, symptoms of associated conditions [sepsis, thyrotoxicosis]
Atrial Fibrillation - mx
Restoration of sinus rhythm - pharmacological cardioversion [B-blocker, propranolol]; DC cardioversion
Antiarrhythmic drugs - amiodarone, digoxin
Rate control - b-blocker or verapamil
DOAC for anticoagulation to prevent/minimise stroke risk - apixaban, rivaroxaban
most people will end up on bisoprolol and a DOAC [apixaban]
How to calculate a CHA2DS2-VASc score
Congestive Heart Failure hx - 1p
Hypertension hx - 1p
Age >=75 - 2p
Diabetes hx - 1p
Stroke/TIA/thromboembolism hx - 2p
Vascular disease hx - 1p
Age 65-74 - 1p
Sex category [female] - 1p
What to do with a CHA2DS2-VASc score?
NICE recommends:
0- no anticoagulation
1- consider anticoagulation in men
2+- offer anticoagulation
Stable Angina - definition/pathophysiology
Caused by atherosclerosis affecting coronary arteries, narrowing lumen and reducing blood flow to myocardium
During times of high demand, insufficient supply of blood to meet demand
“Stable” when symptoms only come on with exertion and are always relieved by rest of glyceryl trinitrate
Stable Angina - s/s
3 main features:
Constricting pain expe4rienced in the chest +/- typical radiation to the arm/neck/jaw
Precipitated by physical exertion
Relieved by rest or GTN within 5m
other features:
dyspnoea, palpitations, syncope
Stable Angina - ix
bed: physical examination [cardiovascular], ECG
blood: FBC, U&Es, LFTs, Lipid profile, TFTs, HbA1C and fasting glucose
imaging: CTCA [CT coronary angiogram], invasive coronary angiography
special: cardiac stress testing
Stable Angina - dd
Unstable Angina/ACS
claudication
Stable Angina - mx
Medical management: immediate symptomatic relief [GTN spray], long-term symptomatic relief [bisoprolol, verapamil]
secondary prevention of cvd - four A’s - aspirin 75mg OD; atorvastatin 80mg OD; ACE inhibitor; Already on a b-blocker
Surgical management: PCI or CABG
ACS - definition/pathophysiology
As a result of a thrombus from an atherosclerotic plaque blocking a coronary artery
3 types: Unstable angina, STEMI/N-STEMI
ACS - s/s
central, constricting, crushing chest pain
radiates to the jaw/arms; nausea/vomiting; sweating/clamminess; a feeling of impending doom; sob; palpitations
symptoms continue at rest for >15m
silent MI is when a pt doesn’t experience typical pain during ACS; pt w/ diabetes are at risk of silent MIs due to neuropathy
ACS - ECG changes
STEMI: ST-segment elevation; new left bundle branch block
N-STEMI: ST depression, T wave inversion
ECG leads and arteries and heart area affected
I, aVL, V3-6: left coronary artery: anterolateral
V1-4: Left anterior descending: anterior
I, aVL, V5-6: circumflex artery: lateral
II, III, aVF: right coronary artery: inferior
ACS - ix
bed: ECG
bloods: FBC, U&Es, LFT, lipid profile, glucose, troponins
imaging: CXR, echocardiogram [once stable to assess functionality]
Classification of ACS
STEMI: ST elevation and new left bundle branch block
N-STEMI: raised troponin with either normal ECG or other ECG changes [ST depression/ T wave inverison]
Unstable angina: symptoms suggest ACS, normal troponin, normal ECG or other ECG changes [ST depression/T wave inversion]
ACS - initial mx
CPAIN
Call ambulance
Perform ECG
Aspirin 300mg
Intravenous morphine if required [and antiemetic]
Nitrate [GTN spray]
ROMAN
Reassure
Oxygen if required
Morphine
Aspirin 300mg
Nitrate [GTN spray]
ACS - surgical mx
STEMI within 12hrs
Percutaneous coronary intervention PCI if available within 2hr of presenting [angiography and angioplasty with stenting]
Thrombolysis if PCI is not available within 2hr [streptokinase, alteplase, tenecteplase]
ACS - ongoing mx
Echocardiogram once stable to assess functional damage
Cardiac rehabilitation
Secondary prevention
ACS - secondary prevention 6 A’s mnemonic
Aspirin 75mg OD
Another Antiplatelet clopidogrel for 12/12
Atorvastatin 80mg OD
ACE inhibitor [Ramipril]
Atenolol [or bisoprolol]
Aldosterone antagonist for those with HF
ACS - complications
DREAD
Death
Rupture of heart or papillary muscles
oEdema [heart failure]
Arrhythmia and Aneurysm
Dressler’s syndrome
Aortic Stenosis - s/s
often symptomatic
can have a classic triad of symptoms: angina; dizziness; dyspnoea
Thrill in the aortic area on palpation; slow rising pulse; narrow pulse pressure; exertional syncope
Ejection-systolic, high-pitched murmur
Aortic Stenosis - causes
idiopathic age-related calcification [most common cause]
bicuspid aortic valve
rheumatic heart disease
Aortic Regurgitation - s/s
dyspnoea is the main presenting symptom [develops insidiously in chronic severe AR with LVF symptoms]
Thrill in the aortic area on palpation; collapsing pulse; wide pulse pressure; heart failure and pulmonary oedema
Early diastolic, soft murmur
Aortic Regurgitation - causes
idiopathic age-related weakness
bicuspid aortic valve
connective tissue disorders [Ehlers-Danlos syndrome; Marfan syndrome]
Mitral Stenosis - s/s
main presenting features are exertional dyspnoea and fatigue; can also have ankle swelling, palpitations, haemoptysis; chest pain
Tapping apex beat, malar flush, atrial fibrillation
Mid-diastolic, low-pitched ‘rumbling’ murmur
Mitral Stenosis - causes
Rheumatic heart disease
Infective endocarditis
Mitral Regurgitation - s/s
Thrill in mitral area on palpation, signs of HF and pulmonary oedema, AF, palpitations, fatigue and reduced exercise tolerance, dyspnoea
Pan-systolic, high-pitched ‘whistling’ murmur
Murmur radiates to the left axilla
Third heart sound may be heard
Mitral Regurgitation - causes
Idiopathic weakening of the valve with age
ischaemic heart disease
infective endocarditis
rheumatic heart disease
connective tissue disorders [Ehlers-Danlos, Marfan]
Tricuspid Regurgitation - s/s
Thrill in tricuspid area on palpation, raised JVP, pulsatile liver, peripheral oedema, ascites
Pan-systolic murmur with split second heart sound
Tricuspid Regurgitation - causes
Pressure due to LSHF or pulmonary hypertension
Infective endocarditis
Rheumatic heart disease
Carcinoid syndrome
Ebstein’s anomaly
Connective tissue disorders [Marfan syndrome]
Pulmonary Stenosis - s/s
Thrill in pulmonary area on palpation, raised JVP, peripheral oedema, ascites
Ejection systolic murmur; widely split second heart sound
Pulmonary Stenosis - causes
Usually congenital, may be associated with Noonan syndrome or Tetralogy of Fallot
Heart Failure - causes
Ischaemic heart disease; myocarditis/cardiomyopathy, hypertension, valvular heart disease, arrhythmias
Heart Failure - s/s
Symptoms- breathlessness, cough [pink/white frothy sputum], orthopnoea, paroxysmal nocturnal dyspnoea, peripheral oedema, fatigue
Signs, can include- tachycardia, tachypnoea, hypertension, murmurs on auscultation, 3rd heart sound, bilateral basal crackles, raised JVP, peripheral oedema
Heart Failure - ix
bed: obs, ECG
blood: BNP, U&Es, FBC, LFTs, TFTs, lipid profile, glucose, iron studies
imaging: CXR, echocardiogram
Heart Failure - New York Heart Association Classification
Class I: no limitation on activity
Class II: comfortable at rest; symptomatic with ordinary activities
Class III: comfortable at rest; symptomatic with any activity
Class IV: symptomatic at rest
Heart Failure - medical mx
ACE inhibitor [Ramipril] / ARB [candesartan] can be used if ACEi not tolerated
Beta blocker [Bisoprolol]
Aldosterone antagonist [Spironolactone]
Loop diuretics [Furosemide]
Cardiac Tamponade - definition/pathophysiology
Life-threatening condition caused by compression of the heart from the accumulation of fluid, blood, clots, or gas within the pericardial space
It prevents adequate filling and contraction of the heart
Cardiac Tamponade - causes
Any cause of pericardial effusion or haemorrhage into the pericardium can lead to cardiac tamponade
Common: pericarditis, tuberculosis, iatrogenic [post-invasive cardiac procedure], trauma, malignancy
Uncommon: connective tissue disease, radiation-induced, uraemia, post-MI, aortic dissection, bacterial infection
Cardiac Tamponade - s/s
Acute cardiac tamponade presents as hypotension due to cardiogenic shock
Symptoms- chest pain, dyspnoea, collapse, fatigue, peripheral oedema
Signs- [Beck’s triad: hypotension, elevated venous pressure and muffled heart sounds], tachycardia, pulsus paradoxus, pericardial rub, other features of shock [i.e. cool extremities, peripheral cyanosis, reduced urine output]
Cardiac Tamponade - ix
Diagnosed with urgent echocardiography
bed: obs, ECG
blood: ABG
imaging: urgent echo, CXR, CT or MRI
Cardiac Tamponade - mx
Urgent needle pericardiocentesis - urgent drainage of the pericardial fluid
may be done using anatomical landmarks, with echocardiography guidance or using fluoroscopy in a cardiac suite
cardiac surgery may be an option to drain effusions in some situations
Hypertension - definition
BP above 140/90 in clinical setting
confirmed with ambulatory or home readings above 135/85
Hypertension - causes
Essential HTN accounts for 90% - aka primary hypertension; developed on its own with no secondary cause
Secondary causes: ROPED mnemonic
Renal disease
Obesity
Pregnancy induced or Pre-eclampsia
Endocrine
Drugs [alcohol, steroids, NSAIDs, oestrogen]
Hypertension - complications
Ischaemic heart disease
Cerebrovascular accident
Vascular disease
Hypertensive retinopathy
Hypertensive nephropathy
Vascular dementia
Left ventricular hypertrophy
Heart failure
Hypertension - s/s
Typically asymptomatic however s/s may reflect underlying end organ damage
Symptoms- palpitations, angina, headaches, blurred vision, new neurology [limb weakness, paraesthesia]
Signs- new neurology [limb weakness, paraesthesia], retinopathy, cardiomegaly, arrhythmias, proteinuria
Hypertensive retinopathy - classification
Keith-Wagener Barker grades
Grade 1: generalised arteriolar narrowing [silver wiring]
Grade 2: focal narrowing and arteriovenous nipping
Grade 3: retinal haemorrhages, cotton wool spots
Grade 4: papilloedema
Hypertension - ix
bed: obs, bp, urinalysis, urinary protein creatinine ratio, ECG, direct ophthalmoscopy
blood: FBC, U&Es, fasting glucose, cholesterol, HbA1c
special: ambulatory bp monitoring, renal uss, endocrine tests [if indicated]
Hypertension - Staging
Stage 1: ABPM >135/85 or clinic bp 140/90
Stage 2: ABPM >150/95 or clinic bp >160/100
Stage 3: clinic bp >180/120
Hypertension - mx
Lifestyle- stop smoking, reduce alcohol, improve diet, exercise, decrease caffeine
Medical mx- T2DM or <55 start on ACEi/ARB, then add CCB or Thiazide like diuretic, then all 3 options if still not controlled
>55 or Black/Caribbean origin start on CCB, then add Thiazide like diuretic or ACEi/ARB, then all 3 options if still not controlled
4th option: spironolactone or alpha/beta-blocker depending on K+
Hypertensive emergencies - Malignant/Accelerated HTN
A BP >180/120 with signs of papilloedema and/or retinal haemorrhage
severe condition resulting in neurological, renal and cardiac damage, requiring admission and immediate management
Tx includes: IV Nitroprusside, labetalol and GTN infusions
Hyperlipidaemia - s/s
may only be seen in patients with very high levels of lipids
corneal arcus, tendon xanthoma, xanthelasma
Hyperlipidaemia - ix
Full lipid profile, HbA1c, assess for secondary causes of hyperlipidaemia, assess risk for anti-lipid therapy
Hyperlipidaemia - mx
Lifestyle modifications: dietary advice, physical activity, weight management, alcohol consumption, smoking cessation
Statin [HMG-CoA reductase inhibitor] - atorvastatin 80mg OD, at night
Fibrate - ezetimibe
Bempedoic acid [ACL inhibitor]
PCSK9 inhibitor - alirocumab
Peripheral Arterial Disease - defintion/pathophysiology
Refers to the narrowing of the arteries supplying the limbs and periphery, reducing blood supply. Usually affects lower limbs, resulting in claudication
Peripheral Arterial Disease - risk factors
Non-modifiable: older age, family history, male sex
Modifiable: smoking, alcohol consumption, poor diet, low exercise/sedentary lifestyle, obesity, poor sleep, stress
Peripheral Arterial Disease - medical co-morbidities
diabetes
htn
ckd
inflammatory conditions [rheumatoid arthritis, for example]
atypical antipsychotic medications
Intermittent Claudication - s/s
Crampy pain that predictably occurs after walking a certain distance
After stopping and resting, pain will ease
Critical Limb Ischaemia - s/s
6P’s
Pain
Pallor
Pulseless
Paralysis
Paraesthesia
Perishing cold
typically causes burning pain. Worse at night when leg is raise, as gravity no longer helps pull blood into foot
Peripheral Arterial Disease - s/s
signs of risk factors: tar staining, xanthomata
signs of cvd: missing limbs/digits, midline sternotomy scar, inner calf scarring for saphenous vein harvesting, focal weakness suggestive of previous stroke
weak peripheral pulses on palpation
pallor, cyanosis, dependent rubor, muscle wasting, hair loss, ulcers, poor wound healing, gangrene
reduced skin temperature, reduced sensation, prolonged capillary refill time, changes during Buerger’s test
Arterial Ulcers - description
Caused by ischaemia secondary to inadequate blood supply
smaller than venous
deeper than venous
well defined borders
‘punched-out’ ppearance
occur peripherally [on toes]
reduced bleeding
painful
Venous Ulcers - description
Caused by impaired drainage and pooling of blood in legs
occur after minor injury to leg
larger than arterial
more superficial than arterial
irregular, gently sloping borders
affect the gaiter area [mid-calf to ankle]
less painful than arterial
occur with other signs of chronic venous insufficiency [haemosiderin staining, venous eczema]
Peripheral Arterial Disease - ix
ABPI
Duplex ultrasound
Angiography- CT or MR- using contrast to highlight arterial circulation
ABPI - result interpretation
0.9-1.3 normal
0.6-0.9 mild peripheral arterial disease
0.3-0.6 moderate to severe peripheral disease
0.3 severe disease to critical ischaemia
> 1.3 can indicate calcification of arteries, this is more common in diabetic pts
Intermittent Claudication - mx
Lifestyle changes
Exercise training - structured, supervised program of regularly walking to the point of near-maximal claudication and pain, then resting and repeating
Medical mx- atorvastatin 80mg OD; clopidogrel 75mg OD; Naftidrofuryl oxalate [5HT2 receptor antagonist; peripheral vasodilator]
Surgical mx- endovascular angioplasty and stenting; endarterectomy; bypass surgery
Critical Limb Ischaemia - mx
Urgent referral to vascular team and analgesia for pain
Urgent revascularisation: endovascular angioplasty and stenting; endarterectomy; bypass surgery; amputation if it is not possible to restore blood flow
Acute Limb Ischaemia - mx
Urgent referral to on-call vascular team for assessment
options include: endovascular thrombolysis; endovascular thrombectomy; surgical thrombectomy; endarterectomy; bypass surgery; amputation if it is not possible to restore blood flow
Who is best managed on Coronary Care Unit [CCU]?
MI, ACS, HF, other cardiac problems
AF, AFlutter, other arrhythmias
Acute cardiac problems
Name some CVD risk factors
Hypertension
Smoking
High cholesterol
Diabetes
Inactivity/Sedentary lifestyle
Overweight/obesity
Family history of CVD
Ethnicity [south asian or black african or african caribbean - ++risk of cvd]
Increased age
Male sex
Poor diet
Excessive alcohol consumption
How to combat CVD risk factors
Stop smoking
Have a balanced diet
Exercise regularly
Maintain a healthy weight
Cut down on alcohol
Take medications prescribed to you by doctors
Manage/control other chronic conditions
Diabetes Mellitus Type I - s/s
4 T’s
tired, thirsty, toilet [polyuria], thin [weight loss]
vomiting, mild-moderate dehydration, BMI <25
some patients can present with DKA as their first s/s of DMTI
Diabetes Mellitus Type I - pathophysiology
Destruction of beta-cells in the pancreas leads to the progressive reduction in insulin secretion
Leads to impaired ability to maintain normal blood glucose levels and results in hyperglycaemia
Diabetes Mellitus Type I - differentials
Type II DM
Diabetes insipidus
Steroid therapy
Psychogenic polydipsia
MODY-DM
Diabetes Mellitus Type I - ix
diagnosed when classical clinical features are found in the presence of a raised random blood glucose level
Majority of patients will be children/adolescents, but don’t discount in adults [LADA]
Further investigations if required:
*autoantibodies
*investigations for pancreatic cancer
Diabetes Mellitus Type I - mx
Life-long exogenous insulin to prevent acute complications [DKA] and long-term complications [CKD, IHD, retinopathy]
Some oral hypoglycaemics can be used too
Insulin regimes for TIDM
Basal-bolus: typically involves a rapid/short acting insulin before meals and a long acting insulin for basal requirements. This is the standard approach for patients newly diagnosed with TIDM
one/two/three injections per day: uses both short and intermediate acting insulin
continuous insulin infusion via a pump: uses short/rapid acting insulin. Used in patients who are experiencing troubling hypoglycaemic episodes with multiple daily injections
Blood glucose monitoring in TIDM
All patients with TIDM should be offered continuous blood glucose monitoring known as CGM. There are two types:
real-time continuous CGM: automatically recorded BGs and shown on a handheld device
intermittently scanned CGM: BG measured only when you scan a device over a sensor
Patients don’t have to use CGM, they can instead opt for a capillary blood glucose monitor
Blood glucose targets in TIDM
On waking- 5-7mmol/L
Before meals- 4-7mmol/L
Post meals: test 90m after food, 5-9mmol/L
Treatment targets in TIDM
Long-term control is monitored with HbA1c - should be assessed/repeated every 3-6months to assess glycaemic control
Patients and clinicians should target a HbA1c <48mmol/L
Monitoring for complications of TIDM
regular diabetic assessment is essential for all patients to improve morbidity and mortality
annual basis [or more frequently if required], pts should receive a diabetic review. includes assessment of injection site problems, retinopathy, nephropathy, diabetic foot problems, cardiovascular risk factors and thyroid disease
retinopathy- annual screening
nephropathy- renal function [eGFR] and albumin:creatinine ratio
diabetic foot problems- full examination including footwear, monofilament assessment of neuropathy, vascular assessment +/- dopplers
cardiovascular- primary/secondary prevention strategy with optimisation of bp, lipids, weight, smoking and others
thyroid- tfts
dental disease- advise regular oral health review
How to safely prescribe insulin
Use a special insulin prescribing chart
MUST write Units, not U
Specify the brand name and indicate the device the patient uses [vial, pen, pen cartridge, pump]
Write pre-breakfast/lunch/dinner instead of times if insulin must be taken before meals
Ensure you confirm with their prescription if unsure of the dose - never estimate
Diabetes Mellitus Type II - s/s
May be asymptomatic
May have: lethargy, polyuria, polydipsia, weight loss, recurrent infections [thrush, balanitis]
Diabetes Mellitus Type II - ix
major diagnostic tool is the measurement of glycated haemoglobin HbA1c
Symptomatic and elevated HbA1c = diagnosis
Asymptomatic and elevated HbA1c = repeat HbA1c, if that’s elevated then a diagnosis can be made
Diabetes Mellitus Type II - mx
- lifestyle advice
- antidiabetic drugs
- insulin use in tiidm
Diabetes Mellitus Type II - lifestyle advice
dietary changes - healthy and balanced, plenty of fibre, low-index carbohydrate and controlling intake of high-fat foods; weight loss may be appropriate
exercise and physical activity - can help lower blood glucose; at least 150 minutes of moderate intensity activity over a weekly period
alcohol consumption - increases weight and may exacerbate or prolong hypoglycaemia induced by oral hypoglycaemic
smoking cessation - should be available and offered to all patients
Antidiabetic drugs - metformin
Metformin is one of most common medications in TIIDM - biguanide; lowers BG through inhibiting hepatic gluconeogenesis and increasing peripheral insulin sensitivity; first line unless contra-indicated [poorly tolerated, CKD, risk of lactic acidosis]
Antidiabetic drugs - sulfonylureas
exs- Gliclazide, glipizide, glimepiride, tolbutamide
moa- Stimulate the pancreas to produce more insulin
c/i- porphyria; ketoacidosis; renal impairment; hepatic impairment
s/e- abdo pain/n/v/d/c, hepatic impairment, weight gain, rash, pruritus, angioedema, erythema, hypoglycaemia, hyponatraemia, dizziness/tremor/drowsiness
d/i- beta-blockers, other antidiabetic drugs, alcohol, steroids, some abx, phenytoin
Antidiabetic drugs - DPP-4 inhibitors
exs- sitagliptin, saxagliptin, alogliptin
moa- blocks DPP-4 enzyme; increases levels of incretins to inhibit glucagon release and increase insulin secretion
c/i- ketoacidosis, hepatic impairment, heart failure, pancreatitis, elderly
s/e- c/v/n/d, gord, gastritis, pancreatitis, headache, dizziness, tremor, back pain, arthralgia, increased risk of infections
d/i- b-blocker, acei, digoxin, rifampicin, other antidiabetics, alcohol, steroids
Antidiabetic drugs - glitazones
exs- pioglitazone
moa- activate ppar[gamma]; enhances tissue sensitivity to insulin and reduces hepatic gluconeogenesis
c/i- HF, bladder cancer, hepatic impairment, elderly, insulin, rf for bone fracture, bladder cancer, hf
s/e- ++fractures, ++infection, bladder cancer, hepatic impairment, numbness, visual impairment, weight gain, insomnia
d/i- b-blockers, nsaids, other antidiabetic drugs
Antidiabetic drugs - SGLT-2 inhibitors
exs- empagliflozin, dapagliflozin
moa- blocks sglt2 transporter in proximal convoluted tubule, stopping reabsorption of glucose
c/i- dka, renal impairment, increasing age, active foot disease, hepatic impairment
s/e- uti, urosepsis, vulvovaginitis, balanoposthitis, fournier’s gangrene, constipation/nausea, thirst, dyslipidaemia, lower limb amputation, renal impairment
d/i- thiazides and loops diuretics, insulin, digoxin, lithium
Antidiabetic drugs - GLP-1 receptor agonists
exs- exanatide, dulaglutide, semaglutide [administered as a sc injection]
moa- activates GLP-1 receptor; increases insulin secretion and decreases glucagon secretion ; slows gastric emptying and decreases food intake
c/i- ketoacidosis, pancreatitis, renal impairment, hepatic impairment, gi disease
s/e- acute pancreatitis, n/v/d, gord, gallbladder disorders/cholecystitis/cholelithiasis, headache, drowsiness, dizziness, renal impairment, sinus tachy, skin reactions
d/i- b-blockers, paracetamol, warfarin, other antidiabetic drugs
Insulin-based regimes for TIIDM
should be considered in patients with poor glycaemic control despite dual antidiabetic with metformin and another agent
regimes include:
1. once/twice daily intermediate acting insulin
2. intermediate insulin along a short acting as separate injections or a premixed formula
3. once daily long acting insulin therapy
4. basal/bolus regimes
Treatment targets for TIIDM
largely based on serial measurements of HbA1c
mx with lifestyle: <48mmol/L
mx with lifestyle and single antidiabetic agent: <48mmol/L
mx with drug associated with hypoglycaemia: <53mmol/L
mx with higher intensification regimes: <53mmol/L
DKA - pathophysiology
Inability to utilise glucose leads to an accumulation of glucose within the blood
As glucose can’t be utilised, glycogen stores are broken down [glycogenolysis] and there’s an increased formation of glucose from other substrates [gluconeogenesis]
Lack of use of glucoes leads to the breakdown of fats [lipolysis] to increase fatty acids; these are used in ketogenesis
Ketone bodies [acetone, beta-hydroxybutyrate and acetoacetate] are increased in the blood - leading to ketonaemia; they are weak acids, leads to significant acidosis and severe illness in increasing quantities
DKA - s/s
Symptoms- nausea, vomiting, polyuria, polydipsia, abdominal pain, leg cramps, headache
Signs- abdominal tenderness, dehydration, hypotension, Kussmaul breathing, reduced consciousness, coma
DKA - diagnosis criteria
Diagnosis is made on identification of biochemical triad of hyperglycaemia, acidaemia, ketonaemia/ketonuria
Lab glucose: >11.0mmol/L
VBG/ABG: <7.3 or bicarb <15mmol/L
Ketone: cap. >=3mmol/L or urinary +++ or above
DKA - ix
bed: ECG, urinalysis +/-MSU, beta hcg
blood: FBC, U&Es, CRP, LFTs, cultures, troponin
imaging: CXR
DKA - main goals of management
*restore circulating volume and tissue perfusion
*clear serum/urinary ketones and halt ketogenesis
*decrease serum glucose towards a normal level
*correct electrolyte derangements
*identify and treat underlying precipitant
DKA - referral to high dependency unit [level 2 care]
One or more of the following
*blood ketone >6mmol/L
*bicarbonate level <5mmol/L
*pH <7.0
*GCS <=12
*Systolic BP <90mmHg
*Hypokalaemia on admission <3.5mmol/L
DKA - circulating volume mx
Fluid of choice is usually 0.9% NaCl
1L over 1hr, then 2Ls each over 2hrs, then 2Ls each over 4hrs
DKA - potassium replacement
IV insulin regime reduces K+ so potassium should be monitored closely and potassium should be added to the fluids when necessary/indicated
DKA - insulin therapy
patients are started on a fixed rate IV infusion
0.1units/kg/hour
infusion is set up using 50units of short acting insulin with 50mls of 0.9% saline
When blood glucose drops <14mmol/L, IV 10% dextrose should be administered at 125ml/hr
continue with patients long-acting insulin
DKA - monitoring during treatment
Each hour blood ketones and glucose should be checked
VBG should be used at 1hr, 2hrs and then 2hrs thereafter
K+ checked every 4hrs minimum within first 24hrs
consider cardiac and saturation monitoring
fluid input/output chart should be kept
DKA - treatment targets
blood ketones: fall by >=0.5mmol/L/hr
bicarbonate: rise by >=3.0mmol/L/hr
blood glucose: fall by >=3.0mmol/L/hr
poatssium: maintain between 4-5.5mmol/L
Hyperglycaemic hyperosmolar state [HHS] - pathophysiology
Relative lack of insulin coupled with a rise in counter-regulatory hormones [cortisol, growth hormone, glucagon] that leads to a profound rise in glucose
reduced glucose utilisation, increased gluconeogenesis and glycogenolysis leads to hyperglycaemia and osmotic diuresis [increased urination due to increased glucose in the urine]
as water is lost, there is profound dehydration and reduced circulating volume - results in hyperosmolarity and hyperglycaemia
Hyperglycaemic hyperosmolar state [HHS] - s/s
Usually insidious onset, with development of increased renal water loss and dehydration over days-weeks
Symptoms- polydipsia, polyuria, nausea, vomiting, muscle cramps, weakness, altered mental status, seizures, coma
Signs- dehydration, hypotension, decreased urine output, decreased conscious level, coma, focal neurology signs, features of a precipitating cause
Hyperglycaemic hyperosmolar state [HHS] - diagnosis
based on identification of characteristic features:
lab glucose: >30mmol/L
serum osmolality: >320mOsm/kg [2NA + urea + glucose]
ketones: urine 1+, trace, negative OR blood <3mmol/L
Hyperglycaemic hyperosmolar state [HHS] - ix
bed: ECG, urinalysis +/- MSU, beta hcg
blood: FBC, U&Es, CRP, LFTs, blood cultures, troponin, amylase, CK
imaging: CXR, CT head [if reduced GCS or focal neurology]
Hyperglycaemic hyperosmolar state [HHS] - management principles
*normalise osmolality
*normalise blood glucose
*replace fluid and electrolytes
*prevention of arterial/venous thrombosis
*prevention of complications and foot ulceration
Hyperglycaemic hyperosmolar state [HHS] - referral to HDU
*osmolality >350mOsm/kg
*sodium >160mmol/L
*pH <7.1
*GCS <12
*systolic BP <90mmHg
*serum creatinine >200μmol/L
*macrovascular event [mi, cva]
*severe electrolyte abnormalities [hyper/hypokalaemia]
Hyperglycaemic hyperosmolar state [HHS] - IV fluids
0.9% normal saline; at least 1L should be given over an hour
further fluids can be given, aiming for a positive fluid balance based on hourly measurement of urine output
rapid correction of fluid deficit is not advisable as it can precipitate osmolar shifts leading to cerebral oedema - aim for 4L positive within the first 24hrs
Hyperglycaemic hyperosmolar state [HHS] - insulin therapy
should only be commenced if there’s evidence of significant ketonaemia
should be given as a fixed rate iv insulin infusion at 0.05units/kg/hr
Hyperglycaemic hyperosmolar state [HHS] - electrolyte replacement
sodium, potassium, phosphate and magnesium should be monitored regularly [4hrly min.] and replaced as necessary
Hyperglycaemic hyperosmolar state [HHS] - monitoring
should be on cardiac monitoring and assessed at regular intervals
every hour- blood glucose, urea and electrolytes and lab/calculated osmolality should be completed for the first 6hr
satisfactory fall in osmolality [3-8mOsm/kg/hr] and glucose [5mmol/L/hr] then bloods reduced to two hourly
Diabetic Foot Ulcer - s/s
often painless
drainage/pus from the foot; unusual swelling; irritation; erythema; odour
partial/complete gangrene can appear around the ulcer depending on severity - odours, discharge, pain and numbness can occur alongside
Diabetic Foot Ulcer - management
X-rays; MRI; bone scans
non-surgical: shoe modification; wound care; total contact casting
surgical: surgical debridement, abx, contact casting; ostectomy; partial calcanectomy; amputation
better management of diabetes or glycaemic control
Retinopathy - s/s
on viewing the retina:
dot and blot haemorrhages, hard exudates, cotton wool spots
intraretinal microvascular abnormalities, venous beading
new vessels at the disc and elsewhere, fibrosis, traction retinal detachment
exudates, oedema
persistent damage to the retina leads to areas of ischaemia and release of angiogenetic factors [e.g. vascular endothelial growth factor]; this promotes new formation of vessels that are weak and friable and consequently leads to complications such as haemorrhage, fibrosis, and retinal detachment
Retinopathy - mx
Good glycaemic control and regular screening to assess early changes are key to preventing and managing disease
photocoagulation is used to manage proliferative disease - aim is to burn holes within the ischaemic retina to prevent release of angiogenesis factors
Nephropathy - s/s
Earliest sign is presence of microalbuminuria, is assessed with an albumin:creatinine ratio
Microalbuminuria is a marker of systemic microvascular damage
CKD in diabetes is evidence by a persistently low eGFR <60mmol/L and/or AC persistently >3mg/mmol/L
Nephropathy - mx
Patients should be treated with an ACE inhibitor or ARB, even in the presence of normotension
TIIDM and CKD: consider SGLT2 inhibitor
Neuropathy - s/s
Peripheral neuropathy occurs in leg secondary to loss of vibration, pain, temperature sensation - symmetrical polyneuropathy
damage to a single cranial or peripheral nerve - mononeuropathy
symmetrical pain, weakness, wasting of proximal muscles of the leg [as a result of disease affecting the lumbosacral plexus] - diabetic amyotrophy
postural hypotension, gastroparesis, diarrhoea, bladder dysfunction, erectile dysfunction - autonomic neuropathy [requires MDC]
Neuropathy - mx
medications for nausea/vomiting, analgesia
maintaining good glycaemic control, cholesterol monitoring, bp monitoring +/- tx
cannot reverse disease, can only manage symptoms and prevent symptoms from getting worse
Hyperglycaemia - s/s
Polyuria; polydipsia; lethargy; thrush/other recurring bladder/skin infections; headaches; blurred vision; weight loss; nausea
Hyperglycaemia - causes
Increased blood sugar in people with diabetes can be caused by stress, illness, eating too much, lack of exercise, dehydration, missing/taking an incorrect dose of medication, over-treating an episode of hypoglycaemia, taking steroids or other medications
Hyperglycaemia - ix
bed: CBG, ECG, beta hcg, urine dip
blood: fbc, u&es, lfts, tfts, VBG/ABG
imaging: -
special: -
Hyperglycaemia - mx
Lifestyle: improve diet, drink plenty of fluids, exercise more often
Medical: adjust insulin or other antidiabetic medications
Hypoglycaemia - s/s
feeling hungry, trembling/shakiness, sweating
in more severe cases- confusion, difficulty concentrating
very severe cases- loss of consciousness
Hypoglycaemia - ix
bed: CBG
blood: fbc, u&es, tfts, VBG/ABG
imaging: -
special: -
Hypoglycaemia - mx
Lift juice, dextrose tablets, something high in sugar
Glucogel
Glucose infusion
Glucagon IM injection
then assess medications and insulin regime - ensure that it’s not too much for the patient
Hypoglycaemia - causes
overdose of diabetes medication
exercise, food, alcohol
fasting/malnutrition
reactive hypoglycaemia - pancreas produces too much insulin after a large carbohydrate-based meal
Addison’s disease
some medications- propranolol, malaria medication
severe illness affecting liver, kidneys or thyroid
Hypernatraemia - s/s
Symptoms- thirst, dehydration, lethargy, fever, n/v/d, confusion, abnormal speech
Signs- dry mucous membranes, postural hypotension, tachycardia, hypotension, altered mental status, oliguria, polyuria
Hypernatraemia - ix
Diagnosis is made on lab sample of plasma sodium >145mmol/L
Urine electrolytes and osmolality can help identify a cause
bloods: FBC, U&Es, LFTs, bone profile, blood glucose, plasma omsolality, CRP/ESR, CK
Hypernatraemia- mx
Restoration of total body water and treating the underlying cause
usually a combination of crystalloids are used to help restore water depletion while not overcorrecting the serum sodium
vital to recheck sodium regularly and fluid balance assessed
Hyponatraemia - s/s
Often asymptomatic, if symptoms present then typically vague and non-specific
Headache, confusion, n/v, lethargy, irritability, seizures, LOC, coma
s/s may also reflect the underlying cause [HF, pancreatitis]
Hyponatraemia - ix
urine: omsolality and sodium
blood: U&Es, glucose, lipids, TFTs, LFTs, early morning cortisol
Acute hyponatraemia - mx
Should be managed in a HDU especially if neurological symptoms present
mild/moderate neurological symptoms- treat underlying cause, medication review, non-essential fluids to be stopped
moderate/severe neurological symptoms- rapid correction of serum sodium using hypertonic saline [1.8-3% saline]
Chronic hyponatraemia - mx
mx is based on underlying cause
hypovolaemic- iv fluid replacement with normal saline, medication review
euvolaemic- fluid restriction as it is typically SIADH; demeclocycline [ADH inhibitor] or vaptan [vasopressin receptor antagonist]
hypervolaemic- treat underlying cause, fluid and salt restriction and use diuretics
Hyponatraemia - complications
cerebral oedema
osmotic demyelination syndrome
Hyperkalaemia - s/s
Frequently asymptomatic and difficult to diagnose without a lab sample
Symptoms- fatigue, generalised weakness, chest pain, palpitations
Signs- arrhythmias, reduced power, reduced reflexes, signs of the underlying cause
Hyperkalaemia - ix
Lab sample of plasma potassium of >=5.5mmol/L; usually achieved by A/VBG
other ix to consider:
urinalysis, ECG, FBC, U&Es, bone profile, CRP, blood cultures, CK
Hyperkalaemia - ECG changes
peaked/tall tented T waves
prolonged PR interval
widening QRS interval
small/absent P waves
AV dissociation
sine wave pattern
asystole
Hyperkalaemia - mx
Medical emergency - ABCDE assessment
ECG, cardiac monitoring, stop any K-containing fluid or medication
Protect myocardium- 30ml of 10% calcium gluconate over 10minutes
Drive potassium intracellularly- insulin infusion 10units of short acting insulin alongside dextrose [50ml 50%] over 30minutes
Eliminate potassium from the body- loop diuretics, potassium-binding resins, haemodialysis
Hypokalaemia - s/s
Symptoms- fatigue, generalised weakness, muscle cramps and pain, palpitations, constipation
Signs- arrhythmias, muscle paralysis and rhabdomyolysis
Hypokalaemia - ix
Diagnosis is based on plasma potassium <3.5mmol/L
other ix to consider:
ECG, urine osmolality and electrolytes, FBC, U&Es, bone profile, magnessium, A/VBG, CK
Hypokalaemia - ECG changes
flat T waves
ST depression
U waves
prolonged PR
Hypokalaemia - mx
mild to moderate - oral replacement route, SANDO-K for example
severe or symptomatic - IV replacement, 40mmol of KCL in 1L of normal saline; if higher K required then should be done in HDU/ITU setting
Hypercalcaemia - s/s
Bones- fragility fractures, bone pain
Stones- renal calculi
Thrones- polyuria, constipation
Abdominal groans- abdo pain, n/v, pancreatitis
Psychic moans- mood disturbance, depression, fatigue, psychosis
other features: myalgia, insomnia, dehydration, hypertension, cardiac arrhythmias
Hypercalcaemia - ix
Confirm hypercalcaemia with a bone profile
PTH levels - helps identify a cause
other ix to consider:
FBC, U&Es, LFT, CRP/ESR, TFTs, Vit D levels, malignancy screen, urine calcium levels, general imaging [CXR, CT chest abdo pelvis if malignancy suspected], parathyroid imaging
Hypercalcaemia - mx
Mild and asymptomatic/mild symptoms- increase oral fluids and avoid precipitants
Moderate- acute rise requires inpatient admission for IV fluids
Severe- all patients require urgent admission to hospital and treatment; aggressive iv fluids and consideration of bisphosphonates, particularly if malignancy is suspected
alternative therapies: corticorsteroids; surgery [1` hyperparathyroidism]; cinacalcet; dialysis
Hypocalcaemia - s/s
Symptoms- paraesthesia, muscle cramps, wheezing, voice changes, CNS disturbances, chest pain, palpitations
Signs- Trousseau’s sign; Chvostek’s sign
Hypocalcaemia - ix
Serum corrected calcium <2.2mmol/L for a diagnosis
consider: bone profile, U&Es, Vit D, parathyroid hormone, magnesium, ECG [can cause prolonged QT interval and arrhythmias]
Hypocalcaemia - mx
Acute severe [<1.9mmol/L] is medical emergency
IV calcium gluconate 10-20ml of 10% calcium gluconate over 10min
Follow up infusion of 100ml 10% in 1L of dextrose 5% or NaCl 0.9%
Treat co-existing pathology- vit d or magnesium
Calcium monitoring
Diabetes Insipidus - patho
results from a deficiency of, or resistance to, anti-diuretic hormone
ADH usually acts on DCT and collecting duct to increase water reabsorption independent of sodium. Stimulates arginine vasopressin receptor 2 leading to insertion of aquaporin-2 channels onto membrane, allowing free entry of water
ADH also causes vasoconstriction of arterioles